Eli Lilly released phase 2b trial results comparing the investigational eloralintide-tirzepatide combo with tirzepatide 15 mg alone in patients with T2D and obesity.
News|Slideshows|September 21, 2024
Now Trending: Fall Vaccine Hesitancy, AI in Respiratory Care
Author(s)Brian Nowosielski
Check out this recap of articles published on our sister sites during the past week.
Advertisement
Explore articles from the past week published on Drug Topics’ sister brands AJMC and Formulary Watch. From a deeper dive into Express Scripts’ lawsuit against the FTC to Medicare price negotiations and their impact on physicians, read up on recent health care industry news.
READ MORE:
Don’t get left behind: Sign up today for our
Advertisement
Related to this article
To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
A newly erected Women’s Health Division within NIH will work in tandem with the Office of Research on Women’s Health.
Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.
Harini Bupathi, Esq, explains why pharmacies need to continue prioritizing PBM relationships despite rapid legislative change.
Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
2
FDA Approves Bepirovirsen Injection to Treat Chronic Hepatitis B
3
American Pharmacists Month: The Evolution from Dispensers to Care Managers
4
EloraTZP Shows Greater Weight Loss, A1C Reduction Than Tirzepatide
5